Genome & Company's Series B Round

Genome & Company raised a round of funding on April 16, 2018.

Genome & Company (지놈앤컴퍼니) is a biotechnology company that is researching microbes and probiotics and developing dietary supplements, cosmeceuticals, and new drugs for obesity, diabetes, ac…

Articles about Genome & Company's Series B Round: